Dr. Nasser K. Altorki
Surgical Oncologist
- 525 East 68th Street, M-404, New York, NY 10065
- (212) 746-5156
After earning his medical degree from Cairo University Faculty of Medicine, Dr. Altorki completed his residency in General Surgery at the University of Illinois Hospital. He holds board certifications in General Surgery and Thoracic Surgery. Recognized by Castle Connolly America’s Top Doctors and recipient of the Society of Thoracic Surgeons Distinguished Service Award, Dr. Altorki is a leader in his field. He is an active member of STS, AATS, and IASLC. His influential research on neoadjuvant therapies and surgical techniques has been published in top-tier journals, including the New England Journal of Medicine, shaping current treatment standards.
Education
- Medical School: Cairo University Faculty of Medicine
- Residency: General Surgery at the University of Illinois Hospital
- Board Certifications: General Surgery, Thoracic Surgery
Awards
- Castle Connolly America’s Top Doctors
- Society of Thoracic Surgeons Distinguished Service Award
- Weill Cornell Medicine Excellence in Clinical Care Award
Professional Memberships and Affiliation
- Society of Thoracic Surgeons (STS)
- American Association for Thoracic Surgery (AATS)
- International Association for the Study of Lung Cancer (IASLC)
Clinical Experience
Dr. Nasser K. Altorki is a highly esteemed surgical oncologist at Weill Cornell Medicine, specializing in lung and esophageal cancers. With a focus on minimally invasive and robotic surgical techniques, he has significantly advanced the field of thoracic surgery. Dr. Altorki is dedicated to improving patient outcomes through innovative surgical methods and personalized treatment plans. His multidisciplinary approach ensures comprehensive care, integrating surgery with adjunct therapies when necessary.
Research and Publications
- Altorki NK, et al. “Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer.” New England Journal of Medicine.
- Altorki NK, et al. “Phase II trial of neoadjuvant bevacizumab plus chemotherapy in stage IB-IIIA non–small-cell lung cancer.” Journal of Clinical Oncology.
- Altorki NK, et al. “Lobectomy for stage IA lung cancer: a randomized controlled trial.” Journal of Thoracic and Cardiovascular Surgery.
Dr. Nasser K. Altorki
Surgical Oncologist
Cancer Treated:
- 525 East 68th Street, M-404, New York, NY 10065
- (212) 746-5156
After earning his medical degree from Cairo University Faculty of Medicine, Dr. Altorki completed his residency in General Surgery at the University of Illinois Hospital. He holds board certifications in General Surgery and Thoracic Surgery. Recognized by Castle Connolly America’s Top Doctors and recipient of the Society of Thoracic Surgeons Distinguished Service Award, Dr. Altorki is a leader in his field. He is an active member of STS, AATS, and IASLC. His influential research on neoadjuvant therapies and surgical techniques has been published in top-tier journals, including the New England Journal of Medicine, shaping current treatment standards.